Cell-specific activation and detoxification of benzene metabolites in mouse and human bone marrow: Identification of target cells and a potential role for modulation of apoptosis in benzene toxicity

Environmental Health Perspectives

Volumn 104, Issue SUPPL. 6, 1996, Pages 1177-1182

  Ross, David ^a   Siegel, David ^a   Schattenberg, Diane G ^a   Sun, Xiaoming M ^a   Moran, Julie L ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

Apoptosis; Benzene; Catechol; CD34+ cells; Cell specific metabolism; Hydroquinone; Myeloperoxidase; NAD(P)H:quinone oxidoreductase; Phenol; Stromal cells

Indexed keywords

1,4 BENZOQUINONE; BENZENE; CD34 ANTIGEN; HYDROQUINONE; PEROXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE);

ANIMAL CELL; APOPTOSIS; BONE MARROW; CELL CULTURE; CELL METABOLISM; CELL STRAIN HL 60; CONFERENCE PAPER; CONTROLLED STUDY; DETOXIFICATION; ENZYME ACTIVITY; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; LEUKEMIA; MACROPHAGE; METABOLITE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMYELOCYTE; STEM CELL; STROMA CELL; TARGET CELL;

EID: 0030458422     PISSN: 00916765     EISSN: None     Source Type: Journal    
DOI: 10.1289/ehp.961041177     Document Type: Conference Paper

References (60)

1. Santesson CG. Uber chronische vergigtung mit steinkohlen-theerbenzin vir todesfalk. Arch Hyg Berlin 31:336-376 (1897).
2. Le Noire MM, Claude H. Sur un cas de purpura attribue a l'intoxication par le benzene. Bull Mem Soc Med Hosp Paris 3:1251 (1897).
3. Delore P, Borgomano J. Leucemie aique au cours de intoxication benzenique. Sur origine toxique de certaines leucemies aigues et leurs relations avec le anemies graves. J Med Lyon 9:227 (1928).
4. Snyder R. The benzene problem in historical perspective. Toxicol Appl Pharmacol 4:692-699 (1984).
5. Anonymous. Organics outpaced inorganics as top 50 chemicals production rose overall. Chem Eng News, April 10:17 (1995).
6. Wallace L. Cigarettes: point source for benzene exposure. Environ Health Perspect 101:14-16 (1993).
7. Wallace LA. Major sources of benzene exposure. Environ Health Perspect 82:165-169 (1989).
8. Aksoy M. Benzene hematotoxicity. In: Benzene Carcinogenicity (Aksoy M, ed). Boca Raton, FL:CRC Press, 1988;59-112.
9. Goldstein BD. Hematotoxicity in humans. J Toxicol Environ Health 2(Suppl):69-105 (1977).
10. Aksoy M. Benzene carcinogenicity. In: Benzene Carcinogenicity (Aksoy M, ed). Boca Raton, FL-CRC Press, 1988;113-151.
11. DeGowin RL. Benzene exposure and aplastic anemia followed by leukemia 15 years later. JAMA 185:748-751 (1963).
12. Cooper KR, Snyder R. Benzene metabolism. In: Benzene Carcinogenicity (Aksoy M, ed). Boca Raton, FL:CRC Press, 1988;33-58.
13. Rickert DE, Baker TS, Bus JS, Barrow CS, Irons RD. Benzene disposition in the rat after exposure by inhalation. Toxicol Appl Pharmacol 49:417-423 (1979).
14. Bainton DF, Ullyot JL, Farquhar MG. The development of neutrophilic polymorphonuclear leukocytes in human bone marrow. J Exp Med 134:907-934 (1971).
15. Sadler A, Subrahmanyam W, Ross D. Oxidation of catechol by horseradish peroxidase and human leukocyte peroxidase: reactions of ο-benzoquinone and ο-benzosemiquinone. Toxicol Appl Pharmacol 93:62-71 (1988).
16. Subrahmanyam VV, Ross D, Eastmond DA, Smith MT. Potential role of free radicals in benzene-induced myelotoxicity and leukemia. Free Radic Biol Med 11:495-515 (1991).
17. Smith MT, Yager JW, Steinmetz K, Eastmond DA. Peroxidase-dependent metabolism of benzene's phenolic metabolites and its potential role in benzene toxicity and carcinogenicity. Environ Health Perspect 82:23-29 (1989).
18. Sawahata T, Neal RA. Horseradish peroxidase-mediated oxidation of phenol. Biochem Biophys Res Commun 109:988-994 (1982).
19. Ross D, Beall H, Traver RD, Siegel D, Phillips RM, Gibson NW. Bioactivation of quinones by DT-diaphorase. Molecular, biochemical and chemical studies. Oncol Res 6:493-500 (1994).
20. Snyder R, Witz G, GoldsteinBD. The toxicology of benzene. Environ Health Perspect 100:293-306 (1993).
21. Gaido K, Wierda D. In vitro effects of benzene metabolites in mouse bone marrow stromal cells. Toxicol Appl Pharmacol 76:45-55 (1984).
22. Gaido K, Wierda D. Modulation of stromal cell function in DBA/2J and B6C3F1 mice exposed to benzene or phenol. Toxicol Appl Pharmacol 81:469-475 (1985).
23. Sutherland HJ, Lansdorp PM, Henkelman DH, Eaves AC, Eaves CJ. Functional characterization of individual human hematopoietic stem cells cultured at limiting dilution on supportive marrow stromal layers. Proc Natl Acad Sci USA 87:3584-3588 (1990).
24. Greaves MF. Stem cell origins of leukemia and curability. Br J Cancer 67:413-423 (1993).
25. Lichtman MA. The ultrastructure of the hemopoietic environment of the marrow: a review. Exp Hematol 9:391-410 (1981).
26. Dorshkind K. Regulation of hemopoiesis by bone marrow stromal cells and their products. Annu Rev Immunol 8:111-137 (1990).
27. Gaido K, Wierda D. Suppression of bone marrow stromal cell function by benzene and hydroquinone is ameliorated by indomethacin. Toxicol Appl Pharmacol 89:378-390 (1987).
28. King AF, Landreth KS, Wierda D. Bone marrow stromal cell regulation of B-lymphopoiesis. II: Mechanisms of hydroquinone inhibition of pre B-cell maturation. J Pharmacol Exp Ther 250:582-590 (1989).
29. Chertkov JL, JD Lutton, Jiang S, da Silva JL, Abraham NG. Hematopoietic effects of benzene inhalation assessed by murine long term bone marrow culture. J Lab Clin Med 119:412-419 (1992).
30. Billips LG, Petitte D, Hostutler R, Tsai P, Landreth KS. Suppression of bone marrow stromal cell function. Ann NY Acad Sci 628:313-322 (1991).
31. Thomas DJ, Sadler A, Subrahmanyam W, Siegel D, Reasor MJ, Wierda D, Ross D. Bone marrow stromal cell bioactivation and detoxification of the benzene metabolite hydroquinone: comparison of macrophages and fibroblastoid cells. Mol Pharmacol 37:255-262 (1990).
32. Thomas DJ, Reasor MJ, Wierda D. Macrophage regulation of myelopoiesis is altered by exposure to the benzene metabolite hydroquinone. Toxicol Appl Pharmacol 97:440-453 (1989).
33. Hay R, Caputo J, Chen TR, Macy M, McClintock P, Reid Y. American Type Culture Collection, Cell Lines and Hybridomas, 8th ed. Rockville, MD, 1994;127.
34. Kojima S, Matsuyama T, Kodera Y. Hematopoietic growth factors released by marrow stromal cells from patients with aplastic anemia. Blood 79:2256-2261 (1992).
35. Schattenberg DG, Stillman WS, Gruntmeir JJ, Helm KM, Irons RD, Ross D. Peroxidase activity in murine and human hematopoietic progenitor cells: potential relevance to benzene-induced toxicity. Mol Pharmacol 46:346-351 (1994).
36. Siegel D, Gibson NW, Preusch PC, Ross D. Metabolism of mitomycin C by DT-diaphorase: role in mitomycin C-induced DNA damage and cytotoxicity in human colon carcinoma cells. Cancer Res 50:7483-7489 (1990).
37. Sun XM, Snowden RT, Skilleter DN, Dinsdale D, Ormerod MG, Cohen GM. A flow cytometric method for the separation and quantitation of normal and apoptotic thymocytes. Anal Biochem 204:351-356 (1992).
38. Wolfe JT, Ross D, Cohen GM. A role for metals and free radicals in the induction of apoptosis in thymocytes. FEBS Lett 352:58-62 (1994).
39. Ross D, Siegel D, Gibson NW, Pacheco D, Thomas DJ, Reasor M, Wierda D. Activation and deactivation of quinones catalyzed by DT-diaphorase. Evidence for bioreductive activation of diaziquone (AZQ) in human tumor cells and detoxification of benzene metabolites in bone marrow stroma. Free Radic Res Commun 8:373-381 (1990).
40. Smart RC, Zannoni VG. DT-Diaphorase and peroxidase influence the covalent binding of the metabolites of phenol, the major metabolite of benzene. Mol Pharmacol 26:105-111 (1984).
41. Twerdok LE, Rembish SJ, Trush MA. Induction of quinone reductase and glutathione in bone marrow cells by 1,2-dithiole-3-thione. Effect on hydroquinone-induced cytotoxicity. Toxicol Appl Pharmacol 112:273-281 (1992).
42. Bhat RV, Subrahmanyam W, Sadler A, Ross D. Bioactivation of catechol in rat and human bone marrow cells. Toxicol Appl Pharmacol 94:297-304 (1988).
43. Smith MT, Robertson ML, Yager JW, Eastmond DA. Role of metabolism in benzene-induced myelotoxicity and leukemo-genesis. Prog Clin Biol Res 340B:125-136 (1990).
44. Sawahata T, Rickert DE, Greenlee WF. Metabolism of benzene and its metabolites in bone marrow. In: Toxicology of the Blood and Bone Marrow (Irons RD, ed). New York:Raven Press, 1985;141-148.
45. Ganousis LG, Goon D, Zyglewska T, Wu KK, Ross D. Cell-specific metabolism in mouse bone marrow stroma: studies of activation and detoxification of benzene metabolites. Mol Pharmacol 42:1118-1125 (1992).
46. Renz JF, Kalf GF. Role for Interleukin-1 (IL1) in benzene-induced hematotoxicity: inhibition of conversion of pre-IL1αα to mature cytokine in murine macrophages by hydroquinone and prevention of benzene-induced hematotoxicity in mice by IL1α. Blood 78:938-944 (1991).
47. Kobayashi, Yamamoto K, Saido T, Kawasaki H, Oppenheim JJ, Matsushima K. Identification of calcium-activated neutral protease as a processing enzyme of human interleukin 1α. Proc Natl Acad Sci USA 87:5548-5552 (1990).
48. Carruth LM, Demczuk S, Mizel SB. Involvement of a calpain-like protease in the processing of the murine interleukin 1α precursor. J Biol Chem 266:12162-12167 (1991).
49. Miller ACK, Schattenberg DG, Malkinson AM, Ross D. Decreased content of the IL1α processing enzyme calpain in murine bone marrow-derived macrophages after treatment with the benzene metabolite hydroquinone. Toxicol Lett 74:177-184 (1994).
50. O'Dowd JJ. The metabolism in vitro of 7,12-dimethylbenz[a]-anthracene by human bone marrow. Cancer Lett 36:83-92 (1987).
51. Selkirk JK, Croy RG, Whitlock JP, Gelboin HV. In vitro metabolism of benzo[a]pyrene by human liver microsomes and lymphocytes. Cancer Res 35:3651-3655 (1975).
52. + normal human hematopoietic cells. Blood 82:2069-2078 (1993).
53. Fairbairn LJ, Cowling GJ, Dexter TM, Rafferty JA, Margison GP, Reipert N. bcl-2 delay of alkylating agent-induced apoptotic death in a murine hemopoietic stem cell line. Mol Carcinog 11:49-55 (1994).
54. Fairbairn LJ, Cowling GJ, Reipert BM; Dexter TM. Suppression of apoptosis allows diffrentiation and development of a multipotent hemopoietic cell line in the absence of added growth factors. Cell 74:823-832 (1993).
55. Gruber J, Greil R. Apoptosis and therapy of malignant diseases of the hematopoietic system. Int Arch Allergy Immunol 105:368-373 (1994).
56. Koury J. Programmed cell death (apoptosis) in hematopoiesis. Exp Hematol 20:391-394 (1992).
57. Raza A, Mundle S, Iftikhar A, Gregory S, Marcus B, Khan Z, Alvi S, Shetty V, Dameron SV, Wright S, Adler S, Loew JM, Shott S, Ali SN, Preisler H. Simultaneous assessment of cell kinetics and programmed cell death in bone marrow biopsies of myelodysplastics reveals extensive apoptosis as the probable basis for ineffective hemopoiesis. Am J Hematol 48:143-154 (1995).
58. Squier MKT, Miller ACK, Malkinson AM, Cohen JJ. Calpain activation in apoptosis. J Cell Physiol 159:229-237 (1994).
59. Williams GT. Programmed cell death: apoptosis and oncogenesis. Cell 65:1097-1098 (1991).
60. Bedi A, Pasricha PJ, Akhtar AJ, Barber JP, Bedi GC, Giardiello FM, Zehnbauer BA, Hamilton SR, Jones RJ. Inhibition of apoptosis during development of colorectal cancer. Cancer Res 55:1811-1816 (1995).